作者@article {Santamaria-Martos1701885 ={桑特amaria-Martos, Fernando and Ben{\'\i}tez, Ivan and Gir{\'o}n, Cristina and Barb{\'e}, Ferran and Mart{\'\i}nez-Garc{\'\i}a, Miguel-Angel and Hern{\'a}ndez, Luis and Montserrat, Josep~M. and Nagore, Eduardo and Martorell, Antonio and Campos-Rodriguez, Francisco and Corral, Jaime and Cabriada, Valentin and Abad, Jorge and Mediano, Olga and Troncoso, Maria F. and Cano-Pumarega, Irene and Fortuna Gutierrez, Ana Maria and Diaz-Cambriles, Trinidad and Somoza-Gonzalez, Maria and Almendros, Isaac and Farre, Ramon and Gozal, David and S{\'a}nchez-de-la-Torre, Manuel}, editor = {,}, title = {Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea}, volume = {51}, number = {3}, elocation-id = {1701885}, year = {2018}, doi = {10.1183/13993003.01885-2017}, publisher = {European Respiratory Society}, abstract = {The goal of this study was to assess the relationship between the severity of obstructive sleep apnoea (OSA) and the levels of carcinogenesis- and tumour growth-related biomarkers in patients with cutaneous melanoma.This multicentre observational study included patients who were newly diagnosed with melanoma. The patients were classified as non-OSA (apnoea{\textendash}hypopnoea index (AHI) 0{\textendash}5 events{\textperiodcentered}h-1), mild OSA (AHI 5{\textendash}15 events{\textperiodcentered}h-1) and moderate{\textendash}severe OSA (AHI \>15 events{\textperiodcentered}h-1). ELISAs were performed to analyse the serum levels of hypoxia- and tumour adhesion-related biomarkers (vascular endothelial growth factor (VEGF), interleukin (IL)-8, intracellular adhesion molecule (ICAM) and vascular cell adhesion molecule (VCAM)-1) and markers of tumour aggressiveness (S100 calcium-binding protein B (S100B) and melanoma inhibitory activity (MIA)). A logistic model adjusted for age, sex and body mass index was fitted to each biomarker, and the AHI served as the dependent variable.360 patients were included (52.2\% male, median (interquartile range) age 55.5 (43.8{\textendash}68.0) years and AHI 8.55 (2.8{\textendash}19.5) events{\textperiodcentered}h-1). The levels of VEGF, IL-8, ICAM-1, S100B and MIA were not related to the severity of OSA. The levels of VCAM-1 were higher in patients with OSA than those without OSA (mild OSA: odds ratio (OR) 2.07, p=0.021; moderate{\textendash}severe OSA: OR 2.35, p=0.013).In patients with cutaneous melanoma, OSA was associated with elevated circulating levels of VCAM-1 that could indicate the contribution of OSA in tumorigenesis via integrin-based adhesion.In patients with cutaneous melanoma, OSA is associated with increased expression of a biomarker of tumorigenesis http://ow.ly/mLo430i9Z8j}, issn = {0903-1936}, URL = {//www.qdcxjkg.com/content/51/3/1701885}, eprint = {//www.qdcxjkg.com/content/51/3/1701885.full.pdf}, journal = {European Respiratory Journal} }